Evidence map›Paper›PMID 33114016›Full record

ArticleInternational journal of molecular sciences2020

Mapping a Circular RNA-microRNA-mRNA-Signaling Regulatory Axis That Modulates Stemness Properties of Cancer Stem Cell Populations in Colorectal Cancer Spheroid Cells.

Vimalan Rengganaten, Chiu-Jung Huang, Ping-Hsing Tsai, Mong-Lien Wang, Yi-Ping Yang, Yuan-Tzu Lan, Wen-Liang Fang, Shelly Soo, Hooi Tin Ong, Soon Keng Cheong and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 45 citations in OpenAlex.

  1. Tumor-suppressive circRNAs in colorectal cancer spheroids and patients.Journal of the Chinese Medical Association : JCMA · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Identification of a gene expression signature associated with brain metastasis in colorectal cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Understanding the role of Cripto-1 in cancer progression and therapeutic strategies.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Vimalan RengganatenCentre for Stem Cell Research, Universiti Tunku Abdul Rahman, Kajang 43000, Malaysia.ORCID 0000-0003-3925-959X
Chiu-Jung HuangDepartment of Animal Science & Graduate Institute of Biotechnology, Chinese Culture University, Taipei 11221, Taiwan.
Ping-Hsing TsaiInstitute of Pharmacology, National Yang-Ming University, Taipei 11221, Taiwan.
Mong-Lien WangDepartment of Medical Research, Taipei Veterans General Hospital, Taipei 11221, Taiwan.ORCID 0000-0002-4060-9131
Yi-Ping YangInstitute of Pharmacology, National Yang-Ming University, Taipei 11221, Taiwan.
Yuan-Tzu LanFaculty of Medicine, National Yang-Ming University, Taipei 11221, Taiwan.
Wen-Liang FangFaculty of Medicine, National Yang-Ming University, Taipei 11221, Taiwan.
Shelly SooCentre for Research on Non-Communicable Diseases, Universiti Tunku Abdul Rahman, 43000 Kajang, Malaysia.
Hooi Tin OngCentre for Stem Cell Research, Universiti Tunku Abdul Rahman, Kajang 43000, Malaysia.
Soon Keng CheongCentre for Stem Cell Research, Universiti Tunku Abdul Rahman, Kajang 43000, Malaysia.
Kong Bung ChooCentre for Stem Cell Research, Universiti Tunku Abdul Rahman, Kajang 43000, Malaysia.
Shih-Hwa ChiouInstitute of Pharmacology, National Yang-Ming University, Taipei 11221, Taiwan.
National Yang Ming Chiao Tung University · TWUniversiti Tunku Abdul Rahman · MYChinese Culture University · TWTaipei Veterans General Hospital · TW

Funding

ANDROGEN REGULATION OF HUMAN SEBACEOUS GLANDSK08AR002018 · NIAMS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI THIBOUTOT, DIANE M. · 1997 to 2001
$225k
Ministry of Science and Technology (MOST, Taiwan) 107-2320-B-010-023Ministry of Science and Technology (MOST, Taiwan) 108-2320-B-010-006Ministry of Science and Technology (MOST, Taiwan) 108-2320-B-010 -019 -MYUniversiti Tunku Abdul Rahman Research Fund (UTARRF) IPSR/RMC/UTARRF/2016-C1/S4Universiti Tunku Abdul Rahman Research Fund (UTARRF) IPSR/RMC/UTARRF/2018-C1/O01
6 · The paper itself

Abstract

Spheroidal cancer cell cultures have been used to enrich cancer stem cells (CSC), which are thought to contribute to important clinical features of tumors. This study aimed to map the regulatory networks driven by circular RNAs (circRNAs) in CSC-enriched colorectal cancer (CRC) spheroid cells. The spheroid cells established from two CRC cell lines acquired stemness properties in pluripotency gene expression and multi-lineage differentiation capacity. Genome-wide sequencing identified 1503 and 636 circRNAs specific to the CRC parental and spheroid cells, respectively. In the CRC spheroids, algorithmic analyses unveiled a core network of mRNAs involved in modulating stemness-associated signaling pathways, driven by a circRNA-microRNA (miRNA)-mRNA axis. The two major circRNAs, hsa_circ_0066631 and hsa_circ_0082096, in this network were significantly up-regulated in expression levels in the spheroid cells. The two circRNAs were predicted to target and were experimentally shown to down-regulate miR-140-3p, miR-224, miR-382, miR-548c-3p and miR-579, confirming circRNA sponging of the targeted miRNAs. Furthermore, the affected miRNAs were demonstrated to inhibit degradation of six mRNA targets, viz. ACVR1C/ALK7, FZD3, IL6ST/GP130, SKIL/SNON, SMAD2 and WNT5, in the CRC spheroid cells. These mRNAs encode proteins that are reported to variously regulate the GP130/Stat, Activin/Nodal, TGF-β/SMAD or Wnt/β-catenin signaling pathways in controlling various aspects of CSC stemness. Using the CRC spheroid cell model, the novel circRNA-miRNA-mRNA axis mapped in this work forms the foundation for the elucidation of the molecular mechanisms of the complex cellular and biochemical processes that determine CSC stemness properties of cancer cells, and possibly for designing therapeutic strategies for CRC treatment by targeting CSC.

Indexed as

Cell Culture TechniquesCell Line, TumorColorectal NeoplasmsComputational BiologyExome SequencingGene Regulatory NetworksHumansMicroRNAsNeoplastic Stem CellsRNA, CircularRNA, MessengerSequence Analysis, RNASpheroids, CellularMicroRNAsRNA, CircularRNA, Messengercircular RNAcolorectal cancercolorectal cancer stem cellsmicroRNAspheroid culturestemness

Identifiers

PMID33114016
PMCPMC7672619
OpenAlexW3093541989

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.